Prostate Cancer and Prostatic Diseases - Table of Contents alert Volume 18 Issue 3

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 18, Issue 3 (September 2015) In this issue Reviews Original Articles Also new AOP Sign up for e-alerts Twitter Recommend to your library Web feed Subscribe Advertisement We are pleased to announce that the Impact Factor* for Prostate Cancer & Prostatic Diseases is now 3.425 - an increase from 2.830 last year. PCAN is ranked 15 of 76 titles in the Urology & Nephrology category and 77 of 211 in the Oncology category. The journal would like to thank all our authors, reviewers and readers for their continued support. (*Thomson Reuters 2014 Journal Citation Reports®) » Submit your research     Reviews Top Physical activity and its mechanistic effects on prostate cancer A Wekesa, M Harrison and R W Watson Prostate Cancer Prostatic Dis 2015 18: 197-207; advance online publication, March 24, 2015; 10.1038/pcan.2015.9 Abstract | Full Text The effect of bicycling on PSA levels: a systematic review and meta-analysis D Jiandani, A Randhawa, R E Brown, R Hamilton, A G Matthew, J L Kuk, S M H Alibhai, E Tufts and D Santa Mina Prostate Cancer Prostatic Dis 2015 18: 208-212; advance online publication, May 5, 2015; 10.1038/pcan.2015.16 Abstract | Full Text Extracellular vesicles such as prostate cancer cell fragments as a fluid biopsy for prostate cancer S I Brett, Y Kim, C N Biggs, J L Chin and H S Leong Prostate Cancer Prostatic Dis 2015 18: 213-220; advance online publication, May 12, 2015; 10.1038/pcan.2015.17 Abstract | Full Text Magnetic resonance imaging on disease reclassification among active surveillance candidates with low-risk prostate cancer: a diagnostic meta-analysis R Guo, L Cai, Y Fan, J Jin, L Zhou and K Zhang Prostate Cancer Prostatic Dis 2015 18: 221-228; advance online publication, May 19, 2015; 10.1038/pcan.2015.20 Abstract | Full Text Original Articles Top High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer OPEN S G Zhao, W C Jackson, V Kothari, M J Schipper, N Erho, J R Evans, C Speers, D A Hamstra, Y S Niknafs, P L Nguyen, E M Schaeffer, A E Ross, R B Den, E A Klein, R B Jenkins, E Davicioni and F Y Feng Prostate Cancer Prostatic Dis 2015 18: 229-236; advance online publication, May 19, 2015; 10.1038/pcan.2015.22 Abstract | Full Text Intraprostatic ethanol diffusion: comparison of two injection methods using ex vivo human prostates B J King, T K Mann-Gow, M Kida, M K Plante, S D Perrapato and P Zvara Prostate Cancer Prostatic Dis 2015 18: 237-241; advance online publication, May 26, 2015; 10.1038/pcan.2015.24 Abstract | Full Text A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer A J Pantuck, C A Pettaway, R Dreicer, J Corman, A Katz, A Ho, W Aronson, W Clark, G Simmons and D Heber Prostate Cancer Prostatic Dis 2015 18: 242-248; advance online publication, July 14, 2015; 10.1038/pcan.2015.32 Abstract | Full Text Acupuncture relieves symptoms in chronic prostatitis/chronic pelvic pain syndrome: a randomized, sham-controlled trial S Sahin, M Bicer, G A Eren, S Tas, V Tugcu, A I Tasci and M Cek Prostate Cancer Prostatic Dis 2015 18: 249-254; advance online publication, May 5, 2015; 10.1038/pcan.2015.13 Abstract | Full Text Rate of Gleason 7 or higher prostate cancer on repeat biopsy after a diagnosis of atypical small acinar proliferation C Warlick, K Feia, J Tomasini, C Iwamoto, B Lindgren and M Risk Prostate Cancer Prostatic Dis 2015 18: 255-259; advance online publication, April 21, 2015; 10.1038/pcan.2015.14 Abstract | Full Text Replication of a genetic variant for prostate cancer-specific mortality K L Penney, I M Shui, Z Feng, H D Sesso, M J Stampfer and J L Stanford Prostate Cancer Prostatic Dis 2015 18: 260-263; advance online publication, May 5, 2015; 10.1038/pcan.2015.18 Abstract | Full Text Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml−1, normal DRE and negative for prostate cancer M H Umbehr, B Gurel, T J Murtola, S Sutcliffe, S B Peskoe, C M Tangen, P J Goodman, I M Thompson, S M Lippman, M S Lucia, H L Parnes, C G Drake, W G Nelson, A M De Marzo and E A Platz Prostate Cancer Prostatic Dis 2015 18: 264-269; advance online publication, May 5, 2015; 10.1038/pcan.2015.19 Abstract | Full Text The biopsy Gleason score 3+4 in a single core does not necessarily reflect an unfavourable pathological disease after radical prostatectomy in comparison with biopsy Gleason score 3+3: looking for larger selection criteria for active surveillance candidates R Schiavina, M Borghesi, E Brunocilla, D Romagnoli, D Diazzi, F Giunchi, V Vagnoni, C V Pultrone, H Dababneh, A Porreca, M Fiorentino and G Martorana Prostate Cancer Prostatic Dis 2015 18: 270-275; advance online publication, June 9, 2015; 10.1038/pcan.2015.21 Abstract | Full Text Integrating chemohormonal therapy and surgery in known or suspected lymph node metastatic prostate cancer A J Zurita, L L Pisters, X Wang, P Troncoso, P Dieringer, J F Ward, J W Davis, C A Pettaway, C J Logothetis and L C Pagliaro Prostate Cancer Prostatic Dis 2015 18: 276-280; advance online publication, May 26, 2015; 10.1038/pcan.2015.23 Abstract | Full Text Effects of resistance training frequency on physical functioning and quality of life in prostate cancer survivors: a pilot randomized controlled trial M K Norris, G J Bell, S North and K S Courneya Prostate Cancer Prostatic Dis 2015 18: 281-287; advance online publication, June 16, 2015; 10.1038/pcan.2015.28 Abstract | Full Text Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidance J P Radtke, S Boxler, T H Kuru, M B Wolf, C D Alt, I V Popeneciu, S Steinemann, C Huettenbrink, C Bergstraesser-Gasch, T Klein, C Kesch, M Roethke, N Becker, W Roth, H-P Schlemmer, M Hohenfellner and B A Hadaschik Prostate Cancer Prostatic Dis 2015 18: 288-296; advance online publication, June 16, 2015; 10.1038/pcan.2015.29 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Prostate Cancer and Prostatic Diseases. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.